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Abstract 
Purpose: Patient falls during hospitalization can delay discharge and decrease 
quality of life. Medications are one factor that can impact fall risk. This study 
examines patients who fell while admitted to a cardiac surgery unit to identify 
which high-risk medications are most prevalent to promote patient safety. 
Methods: This was a retrospective case control study. Adult patients over the 
age of 18 were included. Exclusion criteria included pediatric patients and those 
with an intentional fall event. A total of 39 falls and 78 controls were analyzed in 
the study. The primary outcome was a fall event during hospitalization. Other 
variables included medications, time of medication administration, and risk 
factors.  
Results: The medications significantly more common in patients who fell include 
morphine (31% vs. 6%, p=0.001), insulin glargine (28% vs. 12%, p=0.011), 
amlodipine (23% vs. 10%, p=0.0495), hydralazine (23% vs. 8%, p=0.036), 
isosorbide mononitrate (21% vs. 5%, p=0.02), lorazepam (21% vs. 1%, p<0.001), 
and levothyroxine (21% vs. 5%, p=0.02). Furthermore, 56% of patients who fell 
received two or more medications an hour before the event. Patients who fell 
were significantly more unsteady (41% vs. 5%, p<0.001), impulsive (21% vs. 1%, 
p=0.001) and classified as having an altered mental status (33% vs. 6%, p<0.001). 
After performing a binomial logistic regression, significant medications included 
morphine (OR 10.56, 95% CI 2.704-41.248, p=0.001), lorazepam (OR 31.987, 95% 
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CI 3.179-321.798, p=0.003), and levothyroxine (OR 7.641, 95% CI 1.816-32.146, 
p=0.006).  
Conclusion: Cardiac surgery patients are exposed to multiple high-risk 
medications. Benzodiazepines and potent analgesics may increase fall risk and 
should be closely monitored. Further work is warranted to examine the clinical 
impact of these results in larger patient populations. 
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Background 
 Although much work has already been done to prevent patients from falling 
during hospitalization, it is still a major concern due to the wide array of potential 
complications. The challenge with preventing falls is largely associated with the 
numerous risk factors that are at play (1–3). Additionally, while falls have been well-
characterized, they can vary greatly and each event may be due to unique problems, 
making it hard to accurately predict which patients will fall for one reason or another 
(1,2).  
Although some risk factors are generally unalterable, a patient’s medications are 
one risk that can be impacted through deprescribing or changes in therapy. Also, while 
there are multiple screening tools available to assess a patient’s fall risk, it is unclear if 
they are sufficient when attempting to identify patients most likely to fall (4,5). 
Therefore, it may be beneficial to focus on various risk factors to mitigate individual 
concerns relevant to each patient. There are multiple resources that highlight the 
various risks of medication use. One example is the Stopping Elderly Accidents, Deaths, 
and Injuries (STEADI) initiative through the CDC and American Pharmacist Association. 
There are resources for fall assessment and information on how medications may 
contribute to fall risk based on available literature (6). Additionally, the Beers Criteria 
includes information on potentially inappropriate medications in geriatric patients (7). 
This information can be helpful in all patients, even those that are not classified as 
geriatric (8). Therefore, there is already some information available to identify high-risk 
medications being used during a patient’s hospitalization and their role in fall risk. 
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  Previous studies have contributed a large amount of information regarding how 
medications can affect fall risk. Many of these studies agree with respect to the 
generally accepted classes of high risk medications, including anticonvulsants, 
antipsychotics, benzodiazepines, non-benzodiazepine hypnotics, tricyclic 
antidepressants (TCAs), selective serotonin receptor inhibitors (SSRIs), and opioids (7,9–
11). While each of these medications can impact fall risk in different ways, the Beers 
Criteria recommends avoiding them due to potential for various side effects such as 
dizziness, sedation, and syncope (7). However, many of these medications are often 
necessary, which complicates balancing of fall risk and treatment of conditions. These 
risks can be further increased when patients are in the hospital for surgery, as they are 
often receiving multiple high-risk medications in the perioperative period. Previous work 
has characterized perioperative falls as a significant issue that can persist up to a year 
after discharge (12). 
 When attempting to quantify or assess a patient’s fall risk, screening tools can be 
helpful (4,5,13). One such example is the John Hopkins Fall Risk Assessment Tool (14). 
The validity and predictive value of this tool has previously been studied in home 
healthcare and in the inpatient setting (5,13). This assessment is typically completed by 
a registered nurse and can be repeated throughout a patient’s admission as fall risk may 
change over time. Multiple categories determine how high a patient’s fall risk may be. 
These include age, fall history, incontinence, urinary urgency or frequency, presence of 
high risk medications, patient care equipment, mobility, and cognition are assessed. 
Each risk factor has an assigned value between 1 and 7 points. If the total score is 
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between 6 and 13, the patient has a moderate fall risk. If the score is >13, the patient 
has a high fall risk. In the case of the hospital included in this study, the assessment was 
typically performed upon admission and at least once daily throughout the patient’s 
stay.  
 It is crucial to continue studying fall risk during hospitalization since patients are 
at higher risk for complications due to acute illnesses. While high-risk patients can 
typically be identified, this alone has not proven effective at reducing inpatient falls (15). 
Therefore, the purpose of this study is to focus on patients in cardiac surgery units and 
determine if risk factors are varied in this setting. Some previous studies have used a 
case control design to assess fall risk, but these patients were not specifically 
hospitalized for cardiac-related issues (16). Furthermore, initiation of new medications 
may also contribute to increase in fall risk, especially when the medications contribute 
to orthostatic hypertension or confusion (17). This study intends to identify if timing of 
administration is a potential risk factor for patients who fall. Examining temporal 
relationships may also help determine if chronic or acute medications are stronger 
contributors. Additionally, such relationships can identify when increased monitoring by 
nursing staff following medication administration may be beneficial. Information from 
this study will ideally add to the general knowledge of medication risk and potentially 
identify safer medications to use when fall risk is already elevated for other reasons.  
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Methods 
This study was a retrospective case-control study designed to identify medications that 
increase fall risk for hospitalized patients. The study was conducted at a large academic 
center. The hospital units examined included the cardiovascular surgery step-down 
units, made up of 51 beds total. This was done due to the perceived increase in falls for 
patients in these two units over the period of time included in this study. While the 
patient population in these units is largely post-surgical, some general medicine patients 
were periodically admitted to the unit based on hospital demands and availability of 
beds. Patients with a fall event between January 1, 2015 and June 30, 2016 were eligible 
for inclusion in the study. Falls were identified from the adverse event reports used 
within the hospital to report various events during hospitalization, such as a patient fall. 
These reports were completed by the nurse supervisor upon discovery of the event. If a 
patient fell multiple times during an admission while on either unit, each event was 
included in the study as a separate fall. Patients were excluded if they were under the 
age of 18 or if the fall event was deemed to be intentional. There were some patients 
who attempted to feign a fall to receive medication. As such, they were excluded as it is 
unlikely that medications played a role in their fall. For each fall event, two control 
patients were matched in order to compare risk factors and medications. The control 
patients were from the same unit and had to be hospitalized during the same time 
period as the study. Additionally, the patients were matched by age (±1 year), sex, and 
length of stay (±24 hours).  
7 
 
 Information on each patient was obtained from the electronic medical record. 
Only information from the time of hospitalization was utilized. Age, sex, race, length of 
stay, ICU length of stay, admitting diagnosis, John Hopkins fall risk scores, contributing 
factors, and medication list at the time of falling were collected. Additionally, it was 
noted if a patient received surgery or had a known history of falling. Contributing factors 
were obtained from the John Hopkins Fall Risk Assessment Tool (JH-FRAT), and could 
include advanced age, incontinence, urgency or frequency, presence of high-risk 
medications, lack of independent mobility, unsteady gait, visual or auditory 
impairments, altered awareness, impulsiveness, and lack of understanding (14). These 
assessments were completed by nursing staff at admission and periodically throughout 
a patient’s stay in the hospital. Fall risk scores were calculated using JH-FRAT and were 
placed into three groups: <6 or low risk, 6-13 or moderate risk, and >13 or high risk. For 
patients who fell, the risk score closest to the time of fall was used. For those that did 
not fall, an average score from their stay was calculated. The timing of medications was 
also examined to determine if starting new medications or receiving multiple 
medications at once had an impact on falling. For patients who fell, it was noted if they 
started a new medication within 24 hours of the fall and if they received 2 or more 
medications within an hour of the fall. The same information was collected for each 
control patient, except for information regarding medication initiation or administration 
around time of fall, as this was not applicable. For control patients, the medication list 
was evaluated at 3 days prior to their discharge. This is different from patients who fell, 
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where the medication list reflects what they received immediately around the time of 
their fall.  
 Due to the small sample size expected for this study, statistical analysis was 
performed on the assumption of a non-normal distribution to minimize bias. The Fishers 
Exact Test was used to compare presence of surgery, fall risk score, previous fall, 
contributing factors, and presence of each medication, while the Mann-Whitney U Test 
was used for number of medications and ICU length of stay. A z score for difference of 
proportions was used to compare the prevalence of various medication classes between 
the two groups. In all cases, results with p less than 0.05 were deemed to be statistically 
significant for the purposes of this study. In addition, a binary logistic regression was 
performed to compare medications to each other and determine odds ratios. 
Medications with a p value less than 0.2 after analysis with the Fishers Exact Test were 
included in this analysis.  
After a formal review by the institutional review boards at Indiana University 
Health and Butler University, this study was granted exemption based on study design. 
Results 
A total of 44 falls occurred within the specified date range. After excluding any 
falls that were later determined to be incorrectly classified or intentional, a total of 39 
falls remained for analysis. Therefore, 78 control patients were matched in a 2:1 ratio 
with the fall patients.  
9 
 
 Baseline characteristics for the two groups are noted in Table 1. Of the patients 
who fell, 62% were male and 38% female. Additionally, 74% were white, 26% were 
African American, and no patients in the fall group were Asian, while 6% of control 
patients were. For patients who fell, the median length of stay was 13 days (IQR 19) and 
the median age was 58 (IQR 15). It is also important to note that while this was a cardiac 
surgery unit, only 62% of patients were admitted for a cardiac-related issue. Finally, 
within this study ICU length of stay, rate of surgery, and history of a previous fall were 
not significantly higher in the fall group compared to the control patients. 
 After accounting for the prevalence of various risk factors recorded by the 
nursing staff, the following traits were documented enough for comparisons to be 
made: unsteady, impulsive, altered mental status, incontinence, presence of one high 
risk medication, and presence of two or more high risk medications (Table 2). The 
definition of “high risk” was left to the nurse’s discretion, but were typically classified 
based on the Beers Criteria (7). Of note, 56% of patients who fell received two or more 
medications within one hour of their fall. However, patients receiving at least one high 
risk medication regardless of time were not significantly more likely to fall. Of patients 
that fell, 44% had one high risk medication and 36% had two or more high risk 
medications compared to 60% and 27% in the control group respectively. Of those who 
did fall, 36% did begin a new medication within 24 hours of the fall, however it is not 
known if these new medications increase fall risk. Finally, patients who fell were noted 
to be significantly more unsteady (41% vs. 5%, p<0.001) and impulsive (21% vs. 1%, 
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p=0.001). They were also more likely to be classified as having an altered mental status 
(33% vs. 6%, p<0.001). 
 Johns Hopkins Fall Risk Scores were also compared between the two groups. For 
a score to be used, it must have been recorded around the time of fall, as the score can 
change throughout hospitalization. Of those recorded prior to the fall, 15% of falls and 
33% of controls were <6, indicating a low risk (p=0.049). Additionally, 51% of falls and 
60% of controls were moderate risk with a score of 6-13 (p=0.43), and 10% of falls were 
high risk, with a score >13, compared to none of the control patients (p=0.011).  
Within the fall group, a total of 139 different medications were administered 
during hospitalization. These medications were initially classified into various classes, 
including alpha-1 blockers, anticholinergics, anticonvulsants, antidepressants, 
cardiovascular, anti-infectives, antithrombotics, benzodiazepines, endocrine, 
gastrointestinal, muscle relaxants, non-benzodiazepine hypnotics, analgesics, and other. 
The medication classes were selected based on high risk medication classes as noted by 
the Beers Criteria, with additional classifications added based on common groups of 
medications (7). There was no significant difference in prevalence of medication classes 
between the two groups. Overall, patients who fell were on a larger number of 
medications, with a median total of 15 compared to 12 in patients who did not fall 
(p=0.015). Additionally, the twenty-five most common medications within the fall group 
were compared with their prevalence in the control group. Table 4 includes the full list 
of medications. Of note, 16 of the 25 medications are known to be high-risk for falls 
based on previous studies. Even though many of the medications were previously 
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shown to be high-risk for contributing to a fall, only morphine (31% vs. 6%, p=0.001), 
insulin glargine (28% vs. 12%, p=0.011), amlodipine (23% vs. 10%, p=0.0495), 
hydralazine (23% vs. 8%, p=0.036), isosorbide mononitrate (21% vs. 5%, p=0.02), 
lorazepam (21% vs. 1%, p<0.001), and levothyroxine (21% vs. 5%, p=0.02) were 
significantly more common among patients who fell. Of these 25 medications, those 
with p<0.2 were included in the binary logistic regression. The binary logistic regression 
was statistically significant (χ2(8)=44.67, p<0.001). The model was able to explain 44.1% 
(Nagelkerke R2) of the variance in falling and correctly classified 82.1% of cases. 
However, only three medications were determined to be statistically significant in this 
model. They included morphine (OR 10.56, 95% CI 2.704-41.248, p=0.001), lorazepam 
(OR 31.987, 95% CI 3.179-321.798, p=0.003), and levothyroxine (OR 7.641, 95% CI 
1.816-32.146, p=0.006).  
Discussion 
Although hospitalized patients are subject to increased monitoring in order to 
promote safety, this does not seem to completely counteract the potential harm from 
medications being administered. While the fall and control groups were controlled 
based on age, sex, and length of stay, it was surprising to see that the percentage of 
cardiac-related diagnoses was also equivalent between groups. However, this may be 
due to length of stay unintentionally correlating with admitting diagnosis. Also, while 
ICU length of stay, surgery, and history of falling have all been established as potential 
risk factors, they did not appear relevant for this patient population. However, the large 
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number of post-surgical patients on the units may create a culture of increased 
monitoring due to known fall risk after surgery. 
 When considering the fall risk score, it appeared to be predictive of a patient’s 
fall outcome when at either extreme of the scale (<6 or >13). In both cases, a significant 
majority of patients who fell had a high score and a significant majority of control 
patients had a low score. However, with more than half of fall patients receiving a 
moderate score, which is similar to the control group, the fall risk score may not be 
entirely predictive of which patients will fall. While precious research has confirmed the 
score’s benefit in multiple settings including home health care, many hospitalized 
patients receive a low or moderate risk score which makes it challenging to justify 
interventions (5, 13). Additionally, in this hospital, the score was not often used to guide 
treatment or patient management.  
 Many risk factors known to impact falling were noted to be more common in the 
patients within this study who had a fall event, confirming that having an altered mental 
status, being unsteady, or impulsive are all reasons to increase patient monitoring. Of 
note, being unsteady can often be due to medications that are commonly used in 
cardiac patients, such as beta blockers and other antihypertensives. This may provide an 
important area for more intentional prescribing and seeking out safer alternatives.  
Interestingly, 56% of the patients who fell received two or more medications 
within an hour of their fall and 36% had started a new medication within the last 24 
hours. Although this study was unable to detect a clear association between timing of 
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medication administration and fall risk, this suggests the need for further exploration of 
the ways medication administration can impact fall risk. For example, separating the 
administration of multiple high-risk medications may minimize side effects if given at 
one time. It is also important to note that while receiving one or more high risk 
medications was not significantly more likely in patients who fell, this is likely due to the 
ubiquitous administration of such medications to all patients on a routine basis and the 
small size of this study. Therefore, it is difficult to use presence of high risk medications 
as a concern, although the risk likely increases as the number of medications increases 
beyond one or two. The confirmation of more medications being received by the 
patients who fell highlights the importance of removing unnecessary medications or 
changing the patient to safer alternatives when appropriate. It is much more difficult to 
predict how multiple medications will interact within the patient, so limiting medicines 
to only those that are necessary can prove to be critical. 
 While no medication class was found to be significantly more common among 
patients who fell, this is likely due to patients being admitted for similar diagnoses and 
the hospital formulary limiting the treatment options for these patients. Previous 
literature has already well-establish that many of these drug classes are high risk, and 
this study should not change that view (7). Of the most commonly used medications 
among the patients, only morphine, insulin glargine, amlodipine, hydralazine, isosorbide 
mononitrate, lorazepam, and levothyroxine were significantly more common among 
those who fell. While multiple other medications have already been implicated in fall 
risk, they did not appear to be significantly more common among fall patients within 
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this sample. Part of this may be due to these medications being used too often to detect 
a difference between patients. However, they were also typically less potent and 
therefore may have been less impactful with respect to fall risk. For example, morphine 
was nearly 5 times more prevalent in patients who fell, but hydrocodone-
acetaminophen was nearly equivalent. While it is unclear if the patients receiving 
morphine had acute post-surgical pain or another valid indication, it confirms the need 
to assess pain management and consider a mild analgesic as soon as it is appropriate.  
Furthermore, the use of long-acting insulin highlights the potential benefit of 
carefully watching a patient’s blood glucose during admission. In particular, it is 
important to consider baseline levels and how decreasing glucose dramatically, albeit to 
recommended ranges, may impact their coordination and awareness. This point is also 
valid when considering the three anti-hypertensive medications that were significantly 
more prevalent among fall patients. While amlodipine and isosorbide mononitrate are 
not particularly potent, hydralazine has strong vasodilatory effects that can cause 
dramatic orthostatic hypotension for patients not used to a lower blood pressure. 
Finally, lorazepam use was drastically higher among patients who fell. The use of 
benzodiazepines during hospitalization has severe effects on mental status, indicating 
they should only be used when necessary (10). While levothyroxine was also noted to be 
more common among patients who fell, there is no clear mechanism for why this would 
be at this time. Additional research may be warranted, but this is likely not a true 
association.  
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 While the binary logistic regression was significant, the wide ranges for each 
confidence interval may indicate inaccurate results due to the small sample size. The 
confirmation of morphine and lorazepam as having significant results may help to 
confirm the need for decreasing their use when not truly indicated. However, it is again 
unclear if levothyroxine is truly increasing risk of falls, as previous literature has not 
confirmed this. 
 There are several limitations that must be considered when interpreting results 
from this study. First, the sample size was rather small, which may account for 
differences between this study and previous studies. Additionally, while it was intended 
to study a cardiac population, only about 60% of patients were admitted for a cardiac-
related diagnosis. Hospital formularies can impact prescribing and therefore may 
unintentionally guide medication selection despite known dangers. Finally, it is difficult 
to determine exact timing of when to record the control patients’ medication lists, as 
they often change throughout admission. Despite these limitations, this study does 
attempt to further characterize hospital falls and can serve as further evidence for the 
need to avoid well-established medications with known risks. 
Conclusion 
 Overall, these results help to shed additional light on medications that may be of 
increased risk for hospitalized patients. This study attempted to focus on a population 
that was significantly cardiac-related in order to determine how their risk may differ 
from other patients. However, the study also demonstrates the challenges in seeking 
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meaningful data to use as part of quality improvement. This hospital correctly identified 
increased falls within this unit, but there are still no clear answers as to what caused this 
change. The study was able to highlight several high-risk medications that are still 
prevalent within the units, but further work is needed to confirm if limiting use of such 
agents can effectively decrease fall risk (18). Pharmacists can help impact fall risk by 
monitoring patients for high-risk medications and intervene when changes may help 
improve patient safety (19). However, due to the multifactorial nature of a fall event, 
multidisciplinary approaches with considerations for numerous factors are critical in 
order to meaningfully decrease a patient’s risk of falling and increase their likelihood of 
leaving the hospital without unnecessary and preventable complications.  
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Tables and Figures 
Characteristic Fall, n (%n) Control, n 
(%n) 
p 
Male 24 (62) 48 (62) 1 
Female 15 (38) 30 (38) 1 
White 29 (74) 51 (65) 0.4 
Black 10 (26) 22 (28) 0.83 
Asian 0 (0) 5 (6) 0.17 
Age 58 (15)^ 58 (15)^ 0.99 
LOS 13 (19)^ 12 (15)^ 0.81 
ICU LOS 2 (6)^ 2 (5)^ 0.86 
Surgery 24 (62) 47 (60) 1 
Previous Fall 11 (28) 12 (15) 0.14 
Cardiac Diagnosis 24 (62) 48 (62) 1 
Table 1: Baseline Characteristics. LOS, length of stay; ICU LOS, intensive care unit length 
of stay. ^ denotes data reported as median (interquartile range). 
Contributing Factors: Fall, n(%) Control, n(%) p 
2+ High Risk Meds 14 (36) 21 (27) 0.39 
1 High Risk Med 15 (38) 47 (60) 0.03* 
Incontinence 7 (18) 7 (9) 0.23 
AMS 6 (15) 5 (6) 0.18 
Impulsive 7 (18) 1 (1) 0.002* 
Unsteady 15 (38) 4 (5) <0.001* 
Total Medications 15 (5)^ 12 (8)^ 0.015* 
Table 2: Contributing Factors. ^ denotes data reported as median (interquartile range). * 
denotes statistical significance (p<0.05). 
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Fall Risk Score Fall, n(%) Control, n(%) p 
None 9 (23) 5 (6) 0.043 
<6 6 (15) 26 (33) 0.049* 
6-13 (Moderate) 20 (51) 47 (60) 0.43 
>13 (High) 4 (10) 0 (0) 0.011* 
Table 3: Fall Risk Scores. * denotes statistical significance (p<0.05). 
Medication Class Fall, n Control, n p 
Alpha-1 Blockers 5 7 0.726 
Anticholinergics 11 22 0.674 
Anticonvulsants 10 14 0.617 
Antidepressants 25 34 0.368 
Anti-HTN/CV 92 157 0.968 
Anti-Infectives 28 53 0.667 
Antipsychotics 6 12 0.757 
Antithrombotics 70 153 0.069 
BZDs 11 12 0.271 
Endocrine 38 50 0.204 
GI 67 144 0.099 
Muscle Relaxant 2 1 0.285 
Non-BZD Hypnotics 5 2 0.057 
Pain 61 96 0.575 
Other 128 202 0.401 
Table 4: Prevalence of Medications by Class. 
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Medication Fall, n Control, n p 
Aspirin 26 59 0.38 
Metoprolol 21 36 0.44 
Docusate-Senna 20 43 0.7 
Atorvastatin 17 29 0.55 
Polyethylene Glycol 3350 16 24 0.41 
Pantoprazole 16 24 0.3 
Hydrocodone/Acetaminophen 14 39 0.17 
Enoxaparin 12 27 0.84 
Heparin 12 30 0.54 
Morphine 12 5 0.0013* 
Clopidogrel 11 15 0.35 
Insulin (short acting) 18 24 0.11 
Insulin (long acting) 11 9 0.011* 
Famotidine 11 0 <0.001* 
Amlodipine 9 8 0.0495* 
Furosemide 9 18 1 
Hydralazine 9 6 0.036* 
Hydromorphone 9 11 0.3 
Amiodarone 8 17 1 
Isosorbide Mononitrate 8 4 0.02* 
Lorazepam 8 1 <0.001* 
Levothyroxine 8 4 0.02 
Acetaminophen 8 12 0.6 
Nicotine Patch 8 11 0.43 
Pravastatin 8 8 0.16 
Table 5: Most commonly used medications in patients who fell. * denotes statistical 
significance (p<0.05). 
Medication OR 95% CI P 
Amlodipine 2.668 0.729-9.772 0.138 
Hydralazine 4.022 0.945-17.119 0.06 
Hydrocodone-acetaminophen 0.661 0.241-1.814 0.422 
Insulin (short acting) 2.441 0.896-6.647 0.081 
Isosorbide Mononitrate 1.063 0.202-5.607 0.943 
Levothyroxine 7.641 1.816-32.146 0.006* 
Lorazepam 31.987 3.179-321.798 0.003* 
Morphine 10.56 2.704-41.248 0.001* 
Table 6: Results from a binary logistic regression. * denotes statistical significance 
(p<0.05). 
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